Seemant Chaturvedi/LinkedIn
Sep 6, 2025, 13:18
Seemant Chaturvedi: Will Tirofiban Benefit Patients with Acute Ischemic Stroke?
NEJM Journal Watch shared on X:
”Tirofiban as Thrombolysis Adjunct for Patients with Acute Ischemic Stroke
Patients might have benefited from tirofiban, although these findings require confirmation before clinicians change their practice.”
Read the full review here.
Article: Tirofiban as Thrombolysis Adjunct for Patients with Acute Ischemic Stroke
Author: Seemant Chaturvedi
Stay informed on all science in the field of thrombosis with Hemostasis Today.
-
Sep 14, 2026, 04:43Christina (Tina) P.: Retinopathy Risk With Long-Term HCQ Treatment Detailed in Meta-Analysis
-
Sep 14, 2026, 04:38Aravind Palraj: Uncovering the Drivers of Occlusive Retinal Vasculitis in Young Patients
-
Sep 14, 2026, 04:33Mostafa Elshazly: ERS Has just Relesed 2026 Update on the Treatment of PAH
-
Sep 14, 2026, 04:24Sourabh Dwivedi: Important Hemoglobinopathies – High-Yield-Alert!
-
Sep 14, 2026, 04:14Leonard Valentino: Deeply Grateful to be Nominated for the 2026 Galien Patient First Award
-
Sep 13, 2026, 17:28Jim Hoffman: New Potential Predictive Biomarker for Lupus Nephritis
-
Sep 13, 2026, 17:08W. Alberto Sifuentes Giraldo: Urticarial Vasculitis Clinical Features, Systemic Involvement, and Treatment
-
Sep 13, 2026, 16:58Let’s Debunk Some Myths about Blood in SCD – ASCO
-
Sep 13, 2026, 16:56William Wallace: A Magnesium Ion Decides Whether Your Brain Learns or Not